RBR-10xjp5tz招募中未知
Three-dimensional evaluation of biological effects on the craniofacial complex of surgically assisted rapid maxillary expansion (SARME) and mini-implants (MARPE) in adults - MARPE SARME MARPE - mini-implant assisted rapid palatal expander SARME - surgically assisted rapid maxillary expansion
Faculdade de Odontologia Universidade de São Paulo0 个研究点开始时间: 2022年2月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 25Y 至 45Y（—）
入选标准
- •Brazilian nationality; Craniofacial growth completed; Transverse maxillary deficiency, with or without posterior crossbite, unilateral or bilateral; Age between 25 and 45 years old, male and female; permanent dentition, with at least the first or second permanent upper molars; Good dental conditions and periodontal health. No history of previous orthodontic treatment; Absence of systemic diseases or congenital deformities. Transverse maxillary discrepancy greater than 4mm and less than 10mm
排除标准
- •Absence of permanent maxillary first molars and pre- molars. Presence of deformities or congenital syndromes; Presence of cleft lip and palate; Presence of systemic diseases
研究者
相似试验
已完成
不适用
A study of safety and efficacy of three-dimensional prostate biopsy method for patients with suspected prostate cancersuspected prostate cancerJPRN-UMIN000015331Department of Urology, Keio University School of Medicine200
已完成
不适用
Influence of orthopedic therapy in cleft lip palate patientCTRI/2017/02/007964Yenepoya University36
进行中（未招募）
1 期
Venglustat in Combination with Cerezyme in Adult and Pediatric Patients with Gaucher Disease Type 3Gaucher disease type 3MedDRA version: 20.0Level: PTClassification code 10075699Term: Gaucher's disease type IIISystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-003120-17-FRGenzyme Corporation12
进行中（未招募）
1 期
Venglustat in Combination with Cerezyme in Adult and Pediatric Patients with Gaucher Disease Type 3Gaucher disease type 3MedDRA version: 20.0Level: PTClassification code 10075699Term: Gaucher's disease type IIISystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-003120-17-HUGenzyme Corporation12
进行中（未招募）
1 期
Venglustat in Combination with Cerezyme in Adult and Pediatric Patients with Gaucher Disease Type 3Gaucher disease type 3MedDRA version: 20.0Level: PTClassification code 10075699Term: Gaucher's disease type IIISystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-003120-17-SEGenzyme Corporation12